Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of anti‐angiogenesis agents for the treatment of metastatic and recurrent cervical cancer.

Saved in:
Bibliographic Details
Published in:Cochrane database of systematic reviews 2020-05, Vol.2020 (5)
Main Authors: Rizzuto, Ivana, Otter, Sophie J, Bharathan, Rasiah, Stewart, Alexandra
Format: Article
Language:English
Subjects:
Cancer
CANCER OF THE UTERINE CERVIX
Gynaecology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of anti‐angiogenesis agents for the treatment of metastatic and recurrent cervical cancer.
ISSN:1469-493X
DOI:10.1002/14651858.CD013605